Skip to Main Content

Author Details

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
2017
19
10
PMIDPaper TitleJournal TitlePublished Year
37370018High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist.BMC Cancer2023
37611590USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential.Cell Chem Biol2023
37182843CDK12/13 dual inhibitors are potential therapeutics for acute myeloid leukemia.Br J Haematol2023
35185150Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.Signal Transduct Target Ther2022
35365596Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.Signal Transduct Target Ther2022
36147545Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF1.J Bone Oncol2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
36270774Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB.Life Sci Alliance2022
33610427FBLN1 promotes chondrocyte proliferation by increasing phosphorylation of Smad2.J Orthop Sci2022
34330769Phase Separation of MAGI2-Mediated Complex Underlies Formation of Slit Diaphragm Complex in Glomerular Filtration Barrier.J Am Soc Nephrol2021
32234750CDKL3 promotes osteosarcoma progression by activating Akt/PKB.Life Sci Alliance2020
33123685Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia.Nat Cancer2020
30651561Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.Nat Commun2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
29572350Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.J Biol Chem2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
30559310Two myeloid leukemia cases with rare <i>FLT3</i> fusions.Cold Spring Harb Mol Case Stud2018
28652245Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.Cancer Res2017
28439110Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.Leukemia2017
  • 1 - 19 of 19

Recommended Authors

Huntsman Cancer Institute, The University of Utah
Career Start Year 2017
Number of shared co-authors 8
Versiti Blood Research Institute and Medical College of Wisconsin
Career Start Year 2012
Number of shared co-authors 6
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 4
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 2
Inner Mongolia University
Career Start Year 2010
Number of shared co-authors 13
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 5
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 33
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 11
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 7
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 4
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 14
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 8
University of Parma
Career Start Year 2003
Number of shared co-authors 2
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 2
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 18
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 11
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 5
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 37
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 2
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 4
University of Cambridge
Career Start Year 1996
Number of shared co-authors 7
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 9
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 3
Kyoto University
Career Start Year 1993
Number of shared co-authors 8
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 13
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 19

Collaborators

Oregon Health & Science University School of Medicine
Co-authored papers 10
Oregon Health & Science University, University of California Berkeley
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 7
Oregon Health and Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
University of Texas Southwestern Medical Center
Co-authored papers 4
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Astex Pharmaceuticals
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 3
Ningbo First Hospital
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
AbbVie Inc.
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
University of Utah Huntsman Cancer Institute
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
University of Colorado Division of Hematology
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2